A Study of LY3002813 in Participants With Alzheimer's Disease
NCT01837641
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
63
Enrollment
INDUSTRY
Sponsor class
Conditions
Alzheimer Disease
Interventions
BIOLOGICAL:
LY3002813-IV
BIOLOGICAL:
LY3002813-SC
DRUG:
Placebo-IV
Sponsor
Eli Lilly and Company